1 |

LET´S TALKABOUT THE

IMPORTANCE OF MEIBOMIAN

GLANDS

AN APPROACH TO ADDRESSOCULAR SURFACE HEALTH

2 |

The Johnson & Johnson Vision Meibomian Gland product suite allows eye care care professionals to manage your Ocular Surface Health in four easy steps.

With 86% of all dry eye being attributed to Meibomian Gland Dysfunction (MGD) in one study1 and 300 million dry eye sufferers worldwide, MGD patients represent one of the largest patient segments within eye care practices.2 MGD is prevalent, chronic, and progressive. By evaluating and treating one of the causes, eye care professionals intervene in the progression of the disease, improve gland function, and alleviate dry eye symptoms.

Give Meibomian Gland Dysfunction (MGD) a Second GlanceMeibomian Gland Dysfunction can be treatable.

Assessment of gland structure and function are necessary for a professional to diagnose and manage MGD. Certain parallels can be drawn between the management of MGD and glaucoma. Glaucoma and MGD are both generally diagnosed and managed by measuring function and visualizing structure.

Function & Structure

While dry eye is complex, a leading cause - MGD - is not.

4 |

The Meibomian Gland Product Suite

The LipiScanTM System is a dedicated high definition gland imager designed to image meibomian glands in busy optometric and ophthalmic practices.

The LipiFlow® System is a cleared medical device for Meibomian Gland Dysfunction (MGD) shown to improve gland function.

SYSTEMSYSTEM

TM

6 |

Assess Meibomian Gland Function

Johnson & Johnson Vision’s Standard Patient Evaluation of Eye Dryness (SPEED) questionnaire, validated by the Centre for Contact Lens Research at the School of Optometry and Vision Science at the University of Waterloo, was designed for use by eye care practices to quickly screen patients’ dry eye symptoms. Patients with dry eye symptoms may benefit from the LipiFlow® System treatment for evaporative dry eye.

The SPEED questionnaire assesses frequency and severity of patients’ dry eye symptoms. It examines the occurrence of symptoms on the current day, past 72 hours and past three months. With only four simple questions, the SPEED questionnaire can be easily administered in approximately two minutes. The SPEED score is then easily tallied to quickly obtain relevant dry eye patient symptom information.

The Meibomian Gland Evaluator (MGE) provides a standardized, repeatable evaluation of meibomian gland function by applying the pressure of a deliberate blink while observing gland secretions through a slit lamp.

The MGE can be easily added into a routine eye exam and allows eye care professionals to determine function, track progression, and treatment response.

Features:• Standardized, repeatable evaluation of meibomian gland function

• Easily added into a routine eye exam• Determine function and track treatment progression

• Affordable for every eye care professional

The Meibomian Gland Evaluator (MGE)

1 Validated SPEEDDry Eye Questionnaire MGE2

8 |

Meibomian gland imaging to fit your workflow. A dedicated gland imager for your eye health practice - fast, user-friendly, high-definition images.

Fast - 10 second imaging rapidly captures structure of meibomian glands

User-Friendly - interface designed for ease of image capture (two steps) by a single operator.

High Definition - see your patients’ glands with Dynamic Meibomian Imaging (DMI) technology.

Versatile - Durable, but with a small footprint. At less than 11 kg, it can be used anywhere in lighted lanes (no need for a darkened room).

Specifications

• Illumination: near-infrared (NIR)

• Camera: NIR-sensitive camera

• Dimensions: 406 mm L, 315 mm W, 467 mm H

• Lid Everter: transilluminating

• Storage: Solid State Drive for LipiScanTM System application; SD card for patient records

Reveal meibomian glands efficiently – A new era in routine assessment of meibomian gland health

for Rapid HD Meibomian Imaging

LipiScanTM System3

• Workflow maximization with fast capture of meibomian gland images

• Small footprint and lightweight (11 kg) for optimal versatility

• Fast and intuitive operation for seamless integration into routine workups

• Affordably priced to furnish small practices or multiple locations

• Renders high-definition image of meibomian gland structure

• Export images to EMR

How LipiScanTM System works

10 |

See meibomian gland structure in high definition with Dynamic Meibomian Imaging (DMI)

Now LipiScanTM System completes HD imaging while maximizing your workflow.

Dynamic Illumination surface lighting originates from multiple light sources to minimize reflection.

Adaptive Transillumination changes the light intensity across the surface of the illuminator to compensate for lid thickness variations between patients.

Designed to be placed at locations such us:

Dual-Mode DMI combination of Dynamic Illumination and Adaptive Transillumination offers a multidimensional view of meibomian gland structure.

• Pretest/Evaluating Area• Health Screenings• Cataract & Refractive Locations• Satellite Locations• Contact Lens Service• Referring Practices

LipiFlow® Activator featuring VTP technology

• Feedback Guided

• Therapeutic

• Cornea Shield

• Force Equalization

The LipiFlow® System is a cleared medical device for Meibomian Gland Dysfunction shown to improve gland function. It has been successfully used in over 200,000 treatments.*

Utilizing patented Vector Thermo Pulsation (VTP) technology, the LipiFlow® System applies heat and pressure to the inner eyelid, optimizing its ability to heat and clear the meibomian glands and safely remove gland obstructions and stagnant gland contents.

Delivered through the LipiFlow®

Activator, VTP technology maximizes results and minimizes discomfort. Patented vectored heat and adaptive force equalization targets pulsation, heat, and pressure on the meibomian glands to maximize effectiveness.

Therapeutic motion rolls from base to lid margin releasing stagnant contents from the glands.

LipiFlow® Activator, a single-use sterile device, safely and comfortably delivers automated therapeutic energies to each meibomian gland from the inside while protecting the delicate structures of the patient’s eye. Backed by 7 years of dedicated research and supported by 54 US patents and 76 patents worldwide, LipiFlow® Activator provides a level of accuracy and quality that allows eye care professionals to treat their MGD (Meibomian Gland Dysfunction) patients with confidence and ease.

4 LipiFlow® System

Treat MGD 12 |

4

*Data on file, TearScience, Inc.

14 |

A global brand recognized by patients

1. DRIVEN BY CONSTANT INNOVATION2. A GLOBAL BRAND RECOGNIZED BY PATIENTS3. OFFERING OUTSTANDING SERVICE AND SUPPORT

Driven by constant innovation Offering outstanding service and support1

2

3

*Brands available in specific markets

BEST-IN-CLASS SUPPORT

OUTSTANDINGTRAINING

PRACTICE DEVELOPMENT

IOLCALCULATORS

TECHNICALCUSTOMER

SPECIALISTS

QUALITY ASSURANCE

DEPARTMENTS

COMPLIANCE PROCESSES

SALES SPECIALISTS

MEDICALAFFAIRS

ONLINEORDERING

SYSTEM

@

VISIONEXPERIENCE

CENTRE

FUTURESTARS

SYSTEM

SYSTEM

SYSTEM

16 |

© Johnson & Johnson Surgical Vision, Inc. 2018. PP2018TS4037

Hel

lobo

ok_K

W_0

4/20

18

Array, blink, ClariFlex, CATALYS, Healon, iDesign, iFS, iLASIK, IntraLase, LipiScan, LipiFlow, LipiView, OptiBlue, PhacoFlex, Sensar, Sovereign, TECNIS, TECNIS Symfony, VISX and WHITESTAR SIGNATURE, are trademarks of Johnson & Johnson Surgical Vision Inc.

REFERENCES1. Lemp MA, et al. Distribution of Aqueous-Deficient and Evaporative Dry Eye in a Cllinic-Based Patient Cohort: A Retrospective Study. Cornea 2012;31:472-478. REF2017CT0217.

2. Market Scope: 2016 Dry Eye Products Report: A Global Market Analysis for 2015 to 2021. REF2018TS4011.

For healthcare professionals only.

The Meibomian Gland Product Suite

SYSTEM

SYSTEM

TM